Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | PARP1 | P09874 | 9/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 3/20 | 0.51 |
| ▸ | F3 | P13726 | 1/20 | 0.48 |
| ▸ | F2R | P25116 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19665932 | 0.98 | HDAC11 (0.54) | HTR7MEN1KMT2AHDAC11HDAC8 | |
| SCHEMBL19665961 | 0.98 | HDAC11 (0.54) | HTR7MEN1KMT2AHDAC11HDAC8 | |
| SCHEMBL19710767 | 0.95 | HTR7 (0.55) | HTR7MEN1KMT2AHDAC11HDAC8 | |
| SCHEMBL18893559 | 0.89 | MEN1 (0.54) | HTR7MEN1KMT2APARP1PARP10 | |
| SCHEMBL7556750 | 0.87 | HDAC11 (0.57) | HDAC11HDAC8F2RSMN1; SMN2GAA | |
| SCHEMBL9231035 | 0.86 | NR1H4 (0.56) | HDAC11HDAC8F2RNAAA | |
| SCHEMBL6330053 | 0.85 | HDAC11 (0.58) | HDAC11HDAC8NAAA | |
| SCHEMBL21940532 | 0.85 | HDAC11 (0.58) | HDAC11HDAC8NAAA | |
| SCHEMBL11935020 | 0.85 | HTR7 (0.54) | HTR7MEN1KMT2AHDAC8PARP1 | |
| SCHEMBL30012465 | 0.85 | HDAC11 (0.58) | HDAC11HDAC8NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7964735-B2 | Insecticidal 3-acylaminobenzanilides | BAYER CROPSCIENCE AG (DE) | 2011-06-21 | — | — | US | claimed |
| EP-2394986-B1 | 3-AMINOXALYLAMINOBENZAMIDE DERIVATIVES, AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT | AGRO KANESHO CO LTD (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-8541473-B2 | 3-aminoxalyl-aminobenzamide derivatives and insecticidal and miticidal agents containing same as active ingredient | AGRO-KANESHO CO., LTD. (JP) | 2013-09-24 | — | — | US | disclosed |
| US-20120022263-A1 | 3-AMINOXALYL-AMINOBENZAMIDE DERIVATIVES AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT | AGRO-KANESHO CO., LTD. (JP) | 2012-01-26 | — | — | US | disclosed |
| EP-2394986-A1 | 3-AMINOXALYLAMINOBENZAMIDE DERIVATIVES, AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT | Agro-Kanesho Co., Ltd. (JP) | 2011-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022263-A1 | 3-AMINOXALYL-AMINOBENZAMIDE DERIVATIVES AND INSECTICIDAL AND MITICIDAL AGENTS CONTAINING SAME AS ACTIVE INGREDIENT | HDHD5, CBR3, BAK1 | HTR7 664/4885MEN1 1004/4885KMT2A 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.